Among a set of 107 defined targets, 25 major ones are to be achieved by 2012 or 2020 in the framework of our Sustainable Development strategy.

19**) Reducing by 20% the Global Air Emission Index.
 
20**) Reducing by 20% the Global Water Emission Index.
 
21*) Extending the Risk-Based Inspection system for predictive examination of the physical integrity of installations to all the Group’s major-risk sites.
 
22*) Obtaining OHSAS 18001 (e) or equivalent certification for safety-management systems at 30 of our production sites, and ISO, EMAS or equivalent environmental certification for all relevant sites (f).
 
23*) Making available by sites with potential significant environmental impacts, annual data on emissions and releases along the criteria of public databases of PRTR or TRI-type (g), in accordance with the Responsible Care® Global Charter.
 
24*) Establishing projects at all sites that encourage employee participation in the life of the local community.
 
25*) Regularly conducting opinion surveys about our activities among the communities living in the vicinity of our large production sites.

 
(e) OHSAS 18001: Occupational Health and Safety Assessment Series 18001: standard compatible with ISO 9000 and ISO 14001

(f) Including main pharmaceutical manufacturing sites, but excluding sites processing plastic materials to produce pipes and fittings (PipeLife).

(g) PRTR: Pollutant Release and Transfer Register; TRI: Toxic Release Inventory (US).